Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin

31 Aug 2021

Abstract excerpt

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects an individual's reciprocal social interaction and communication ability. Numerous genetic and environmental conditions are associated with ASD, including tuberous sclerosis complex, phosphatase and tensin homolog hamartoma tumor syndrome, fragile X syndrome, and neurofibromatosis 1. The pathogenic molecular mechanisms of these diseases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Genetics and Neurodevelopmental Disorders
Share to Tuberous Sclerosis Complex Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36325164
DOI: 10.1016/j.bpsgos.2021.08.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of RapamycinPMID 36325164Read ↗

The epilepsy-autism spectrum disorder phenotype in the era of molecular genetics and precision therapy.Semantic proximity Read ↗

Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in uteroSemantic proximity Read ↗

Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment.Semantic proximity Read ↗

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.Semantic proximity Read ↗

mTOR dysregulation and tuberous sclerosis-related epilepsySemantic proximity Read ↗

Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.Semantic proximity Read ↗

Molecular neurobiology of mTORSemantic proximity Read ↗

Comprehensive transcriptomic and proteomic profiling of mTOR-related epilepsySemantic proximity Read ↗

Autism Spectrum Disorders in Tuberous Sclerosis: Pathogenetic Pathways and Implications for TreatmentSemantic proximity Read ↗

mTOR: A pathogenic signaling pathway in developmental brain malformations.Semantic proximity Read ↗

mTOR signaling in epilepsy: insights from malformations of cortical development.Semantic proximity Read ↗

Mammalian target of rapamycin: master regulator of cell growth in the nervous system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.